Diethylcarbamazine
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), DBL -Institute for Health Research and Development, University Hospitals Cleveland Medical Center, Indian Council of Medical Research, Lihir Medical Centre
Conditions
Filarial; InfestationFilariasisHIV InfectionHelminthiasisLoiasisLymphatic FilariasisMansonelliasisOnchocerciasis
Phase 2
Effect of Albendazole Dose on Treatment of Lymphatic Filariasis
CompletedNCT00511004
Start: 2007-07-31End: 2014-02-28Updated: 2015-08-31
Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis
CompletedNCT01111305
Start: 2010-04-30End: 2017-09-30Updated: 2022-01-27
Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa
CompletedNCT01975441
Start: 2014-05-31End: 2018-06-30Updated: 2018-10-09
PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )
CompletedNCT03664063
Start: 2018-09-01End: 2019-01-01Updated: 2019-02-28
Phase 3
Phase 4
Unknown Phase
Host Response to Infection and Treatment in Filarial Diseases
RecruitingNCT00001230
Start: 1991-03-15Target: 500Updated: 2026-08-17
Interaction Between HIV and Lymphatic Filariasis
CompletedNCT00295698
Start: 2001-08-31End: 2002-11-30Updated: 2006-02-24
Lymphatic Filariasis (LF) in Ivory Coast
CompletedNCT02974049
Start: 2015-01-31End: 2018-09-25Updated: 2022-04-21